<DOC>
	<DOCNO>NCT00153569</DOCNO>
	<brief_summary>This trial assess clinical efficacy multiepitope peptide vaccine GM-CSF KLH immunological adjuvant stage IV melanoma patient</brief_summary>
	<brief_title>Multiepitope Peptide Vaccination Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Metastatic melanoma HLAA1 , A2 , A24 , B44</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>